Key result
Tea intake linked to ~15% fewer incident IHD cases globally.
Why the study?
Tea intake has been associated with reduced IHD risk, but a comprehensive global assessment of the IHD burden reduction potentially associated with tea intake was lacking.
Does tea intake reduce the incidence and mortality of ischemic heart disease globally?
Observational
Does tea intake reduce the incidence and mortality of ischemic heart disease globally?
Answers are grounded in this paper and cite their sources.
Tea intake is potentially associated with a substantial reduction in the global burden of ischemic heart disease, accounting for an estimated 15.49% of incident cases and 8.32% of deaths in 2021.
Background Tea intake (TI) has been associated with a reduced risk of ischemic heart disease (IHD) through antioxidant, anti-inflammatory, and metabolic regulatory biological mechanisms, but a comprehensive global assessment of the IHD burden reduction potentially associated with TI is lacking. This study aimed to quantify the reductions in global IHD incidence and mortality associated with TI from 1990 to 2021, and explore heterogeneity in these associations across demographic subgroups and regions. Methods We conducted a comparative risk assessment analysis integrating data from the Global Dietary Database (GDD), IHD burden estimates from the Global Burden of Disease (GBD) study, and BMI-stratified population distributions from the NCD Risk Factor Collaboration (NCD-RisC) across 180 countries and regions. TI distributions were modeled using gamma distributions, and BMI-stratified relative risks derived from dose-response meta-analyses were applied to estimate population attributable fractions. The analysis was stratified by sex, age, education level, and urbanicity. Proportional and absolute burden reductions (cases per million adults) were estimated, with uncertainty propagated through Monte Carlo simulation. Results Globally in 2021, approximately 28.66 million (95% UI: 18.76–44.79) IHD incident cases and 4.42 (95% UI: 2.94–6.72) million IHD deaths were potentially attributable to TI, accounting for 15.49% (95% UI: 7.03%–36.85%) and 8.32% (95% UI: 4.60%–15.70%) of total cases and deaths, respectively. The beneficial association was greater in men and middle-aged/older adults, with no significant difference by education level or urbanicity. Regionally, the Middle East and North Africa showed the highest proportional reductions (incidence: 22.04%; mortality: 11.72%), followed by Southeast and East Asia. From 1990 to 2021, Southeast and East Asia and Sub-Saharan Africa saw the largest increases in preventable IHD case proportions. At the national level, countries like Iran, Japan, and Kenya had the highest estimated proportional reductions, while China and Japan contributed the largest absolute reductions in preventable cases per million adults. Conclusion TI is potentially associated with the reduced global burden of IHD, with benefits varying by region and demographic characteristics. These findings underscore the potential of TI as a dietary strategy for cardiovascular disease prevention and can inform targeted policies worldwide.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted an observational in Ischemic heart disease. Tea intake vs. Zero tea intake was evaluated on Proportion of total IHD incident cases potentially preventable by tea intake globally in 2021 (PAF 15.49%, 95% CI 7.03%-36.85%). Tea intake was potentially associated with the prevention of 28.66 million ischemic heart disease incident cases globally in 2021, accounting for 15.49% of total cases.
Synapse has enriched 10 related papers. Consider them for comparative context: